Stock exchanges & markets

Overview Watchlists

Medtronic receives CE Mark for Vitalis pacemaker portfolio

2 hours ago

(AWP Alliance News) - Medtronic received CE Mark for its Vitalis pacemaker portfolio, which includes devices designed for conduction system pacing. The portfolio's ReSyncra CSP pacemaker offers a treatment option for patients in whom effective conventional cardiac resynchronization therapy cannot be achieved.

https://www.publicnow.com/view/8DC789BDAA43FB42D2E6A8B83428E74BB7151A35…

Disclaimer: This news brief was created using generative artificial intelligence. Medtronic plc published the original content used to generate this news brief on October 19, 2026, and is solely responsible for the information contained therein.

Learn more about our offers

  • Keep a close eye on your favourite shares

    Watchlist

    Don’t miss out on share price trends. Track your favourite shares (CH, EU & US) in real time with customised watchlists.

    Sign up now

  • Compare ETFs systematically

    ETF Compass

    Find the products that suit your investment goals.

    Try the ETF Compass

  • How to find the best shares

    theScreener

    Search through around 6,500 securities using criteria such as opportunities and risks or expected dividend yield.

    Test now